Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 8,577,030,400
  • Shares Outstanding, K 49,350
  • 60-Month Beta 0.79
  • Price/Earnings ttm 26.01
  • Annual Dividend & Yield 0.39 (0.22%)
  • Most Recent Dividend 0.183 on 12/16/25
  • Management Fee 0.44%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 21.96% (+0.10%)
  • Historical Volatility 20.83%
  • IV Percentile 43%
  • IV Rank 15.20%
  • IV High 43.73% on 04/08/25
  • IV Low 18.05% on 02/13/25
  • Expected Move (DTE 17) 6.48 (3.73%)
  • Put/Call Vol Ratio 5.80
  • Today's Volume 4,448
  • Volume Avg (30-Day) 3,328
  • Put/Call OI Ratio 1.91
  • Today's Open Interest 55,268
  • Open Int (30-Day) 55,228
  • Expected Range 167.32 to 180.28

Price Performance

See More
Period Period Low Period High Performance
1-Month
165.09 +5.28%
on 01/05/26
179.64 -3.25%
on 01/07/26
+4.80 (+2.84%)
since 01/02/26
3-Month
154.63 +12.40%
on 11/04/25
179.64 -3.25%
on 01/07/26
+16.34 (+10.38%)
since 11/03/25
52-Week
107.43 +61.78%
on 04/09/25
179.64 -3.25%
on 01/07/26
+35.95 (+26.08%)
since 02/03/25

Most Recent Stories

More News
Are Wall Street Analysts Bullish on Moderna Stock?

While Moderna has outpaced the S&P 500 over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.

$SPX : 6,917.81 (-0.84%)
MRK : 115.84 (+2.18%)
IBB : 173.80 (-0.20%)
MRNA : 42.20 (-0.82%)
PIPR : 335.27 (-3.13%)
How to Invest in the New Era of Agentic AI for Biotech Stocks

Our senior market strategist explains which ETFs offer exposure to high-powered biotech growth, without T. Rex-sized risk.

ARKG : 30.32 (-0.98%)
IBB : 173.80 (-0.20%)
XBI : 127.65 (+0.24%)
5 Healthcare Names to Watch as Sector Rotation Is in Full Swing

The healthcare sector is outperforming the broader market and tech sector in Q4, confirming a substantial capital shift into the defensive industry.

NVDA : 180.34 (-2.84%)
XLV : 154.10 (-1.02%)
JNJ : 233.10 (+1.02%)
LLY : 1,003.46 (-3.90%)
IBB : 173.80 (-0.20%)
GILD : 143.28 (+0.27%)
REGN : 759.18 (+0.55%)
AMGN : 338.59 (-1.77%)
UNH : 284.18 (-0.49%)
Are Wall Street Analysts Bullish on Regeneron Pharmaceuticals Stock?

Regeneron Pharmaceuticals has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

$SPX : 6,917.81 (-0.84%)
IBB : 173.80 (-0.20%)
REGN : 759.18 (+0.55%)
Incyte Stock Outlook: Is Wall Street Bullish or Bearish?

Incyte has delivered better returns than the broader market over the past year, and analysts view the stock’s outlook with measured optimism.

$SPX : 6,917.81 (-0.84%)
IBB : 173.80 (-0.20%)
INCY : 100.92 (-1.70%)
Bio-Techne Stock: Is Wall Street Bullish or Bearish?

Despite underperforming the broader market and biotechnology industry over the past year, analysts remain strongly bullish on Bio-Techne’s longer-term prospects.

TECH : 64.63 (-0.95%)
WFC : 92.31 (+0.04%)
$SPX : 6,917.81 (-0.84%)
IBB : 173.80 (-0.20%)
These 3 Biotech ETFs Have Gone Viral, and They All Offer Traders a Cure

Hunting for upside potential typically reserved for the private equity world? Look no further.

SBIO : 52.44 (-0.13%)
GNOM : 47.51 (-0.87%)
IBB : 173.80 (-0.20%)
Biotech Sector May Flip to Market Leader by Year-End

As rate cuts loom and after years of lagging, the biotech sector is showing signs of life, with IBB outpacing the benchmark S&P 500 on the quarter.

IBB : 173.80 (-0.20%)
GILD : 143.28 (+0.27%)
XBI : 127.65 (+0.24%)
IWM : 262.78 (+0.23%)
What Are Wall Street Analysts’ Target Price for Regeneron Pharmaceuticals Stock?

Regeneron’s stock has fallen behind the broader market over the past year, but analysts see potential for growth, tempered with caution.

$SPX : 6,917.81 (-0.84%)
IBB : 173.80 (-0.20%)
REGN : 759.18 (+0.55%)
Are Wall Street Analysts Predicting Incyte Stock Will Climb or Sink?

Incyte has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

$SPX : 6,917.81 (-0.84%)
IBB : 173.80 (-0.20%)
INCY : 100.92 (-1.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

3rd Resistance Point 180.35
2nd Resistance Point 178.61
1st Resistance Point 176.20
Last Price 173.80
1st Support Level 172.05
2nd Support Level 170.31
3rd Support Level 167.90

See More

52-Week High 179.64
Last Price 173.80
Fibonacci 61.8% 152.06
Fibonacci 50% 143.54
Fibonacci 38.2% 135.01
52-Week Low 107.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar